Artificial intelligence revolutionizes early detection of biological aging and cardiovascular risks by analyzing routine medical images, offering non-invasive, scalable tools that outperform traditional methods in identifying subclinical changes before symptoms appear.
Chest X-rays provide a window into cardiopulmonary aging through models like CXR-Age, which estimate biological age by detecting subtle structural shifts in the heart, lungs, and vasculature. When the predicted age exceeds chronological age, it strongly correlates with increased risks of frailty, vascular stiffness, all-cause mortality, and cardiovascular events—often surpassing the accuracy of leading epigenetic clocks such as Horvath or PhenoAge.
Retinal imaging offers another powerful approach, where AI examines microvascular features—including vessel caliber, tortuosity, and branching patterns—to predict systemic risks like hypertension, stroke probability, and major adverse cardiac events with high precision. These models enable opportunistic screening using widely available fundus photographs, particularly valuable for populations with limited access to advanced testing.
Echocardiography advances similarly, with convolutional networks processing video frames to derive cardiac biological age, focusing on key regions like the mitral valve and basal walls. Discrepancies from chronological age link robustly to excess mortality, heart failure, coronary disease, and stroke, providing insights into accelerated cardiac aging beyond conventional metrics.
Multimodal integration—combining ECG signals, echo views, and angiography—further refines predictions for long-term outcomes. These AI-driven biomarkers transform everyday clinical imaging into proactive diagnostic assets, shifting healthcare toward prevention by quantifying hidden risks years in advance.
By embedding these tools into routine workflows, providers gain cost-effective, equitable methods for personalized risk stratification and timely interventions. As datasets expand and models refine, accuracy and applicability continue to improve, democratizing advanced cardiovascular assessment.
AI‘s ability to identify early aging and cardiovascular risks from medical images advances healthcare profoundly, enabling earlier, more precise interventions for better patient outcomes and reduced disease burden.
